nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—PTGS2—skin cancer	0.725	1	CbGaD
Meclofenamic acid—Erythema nodosum—Vemurafenib—skin cancer	0.00856	0.0475	CcSEcCtD
Meclofenamic acid—PTGS2—leg—skin cancer	0.00404	0.067	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—TP53—skin cancer	0.00403	0.436	CrCbGaD
Meclofenamic acid—AKR1C3—nipple—skin cancer	0.00368	0.061	CbGeAlD
Meclofenamic acid—PTGS2—hindlimb—skin cancer	0.00361	0.0598	CbGeAlD
Meclofenamic acid—KCNQ3—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00348	0.139	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00348	0.139	CbGpPWpGaD
Meclofenamic acid—Lupus erythematosus—Docetaxel—skin cancer	0.00338	0.0187	CcSEcCtD
Meclofenamic acid—Ulcer—Imiquimod—skin cancer	0.00334	0.0185	CcSEcCtD
Meclofenamic acid—Visual acuity reduced—Temozolomide—skin cancer	0.00318	0.0177	CcSEcCtD
Meclofenamic acid—KCNQ3—female reproductive system—skin cancer	0.00313	0.0519	CbGeAlD
Meclofenamic acid—PTGS2—appendage—skin cancer	0.00309	0.0513	CbGeAlD
Meclofenamic acid—KCNQ2—female reproductive system—skin cancer	0.00288	0.0478	CbGeAlD
Meclofenamic acid—Alopecia—Vismodegib—skin cancer	0.00266	0.0148	CcSEcCtD
Meclofenamic acid—KCNQ3—head—skin cancer	0.00261	0.0434	CbGeAlD
Meclofenamic acid—PTGS2—skin epidermis—skin cancer	0.00257	0.0427	CbGeAlD
Meclofenamic acid—Dermatitis exfoliative—Imiquimod—skin cancer	0.00243	0.0135	CcSEcCtD
Meclofenamic acid—KCNQ2—head—skin cancer	0.00241	0.0399	CbGeAlD
Meclofenamic acid—Ulcer—Bleomycin—skin cancer	0.00237	0.0132	CcSEcCtD
Meclofenamic acid—ALOX5—connective tissue—skin cancer	0.0023	0.0382	CbGeAlD
Meclofenamic acid—Eosinophilia—Vemurafenib—skin cancer	0.0023	0.0128	CcSEcCtD
Meclofenamic acid—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00227	0.0126	CcSEcCtD
Meclofenamic acid—Ulcer—Dactinomycin—skin cancer	0.00221	0.0123	CcSEcCtD
Meclofenamic acid—AKR1C3—mammalian vulva—skin cancer	0.00215	0.0357	CbGeAlD
Meclofenamic acid—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00205	0.0114	CcSEcCtD
Meclofenamic acid—PTGS1—endothelium—skin cancer	0.00195	0.0324	CbGeAlD
Meclofenamic acid—PTGS2—endothelium—skin cancer	0.00187	0.031	CbGeAlD
Meclofenamic acid—Decreased appetite—Vismodegib—skin cancer	0.00186	0.0103	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Vismodegib—skin cancer	0.00184	0.0102	CcSEcCtD
Meclofenamic acid—Fatigue—Vismodegib—skin cancer	0.00184	0.0102	CcSEcCtD
Meclofenamic acid—Ulcer—Fluorouracil—skin cancer	0.00184	0.0102	CcSEcCtD
Meclofenamic acid—Constipation—Vismodegib—skin cancer	0.00183	0.0101	CcSEcCtD
Meclofenamic acid—PTGS1—blood vessel—skin cancer	0.0018	0.0299	CbGeAlD
Meclofenamic acid—Erythema multiforme—Vemurafenib—skin cancer	0.00176	0.00976	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00175	0.00972	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Vismodegib—skin cancer	0.00175	0.0097	CcSEcCtD
Meclofenamic acid—PTGS2—blood vessel—skin cancer	0.00172	0.0286	CbGeAlD
Meclofenamic acid—Conjunctivitis—Imiquimod—skin cancer	0.00172	0.00953	CcSEcCtD
Meclofenamic acid—Abdominal pain—Vismodegib—skin cancer	0.00169	0.00938	CcSEcCtD
Meclofenamic acid—ALOX5—lymphoid tissue—skin cancer	0.00168	0.0279	CbGeAlD
Meclofenamic acid—SLCO1C1—head—skin cancer	0.00167	0.0278	CbGeAlD
Meclofenamic acid—Alopecia—Vemurafenib—skin cancer	0.00164	0.00912	CcSEcCtD
Meclofenamic acid—ALOX5—female reproductive system—skin cancer	0.00162	0.0269	CbGeAlD
Meclofenamic acid—Haemoglobin—Imiquimod—skin cancer	0.00159	0.00884	CcSEcCtD
Meclofenamic acid—Haemorrhage—Imiquimod—skin cancer	0.00158	0.0088	CcSEcCtD
Meclofenamic acid—Asthenia—Vismodegib—skin cancer	0.00153	0.00851	CcSEcCtD
Meclofenamic acid—Pruritus—Vismodegib—skin cancer	0.00151	0.00839	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Imiquimod—skin cancer	0.0015	0.00832	CcSEcCtD
Meclofenamic acid—Tinnitus—Imiquimod—skin cancer	0.00148	0.0082	CcSEcCtD
Meclofenamic acid—Diarrhoea—Vismodegib—skin cancer	0.00146	0.00812	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Temozolomide—skin cancer	0.00145	0.00808	CcSEcCtD
Meclofenamic acid—Alopecia—Imiquimod—skin cancer	0.0014	0.00778	CcSEcCtD
Meclofenamic acid—Vomiting—Vismodegib—skin cancer	0.00136	0.00754	CcSEcCtD
Meclofenamic acid—ALOX5—head—skin cancer	0.00136	0.0225	CbGeAlD
Meclofenamic acid—Lumiracoxib—PTGS2—skin cancer	0.00134	0.144	CrCbGaD
Meclofenamic acid—KCNQ3—L1CAM interactions—SCN10A—skin cancer	0.00133	0.0532	CbGpPWpGaD
Meclofenamic acid—KCNQ2—L1CAM interactions—SCN10A—skin cancer	0.00133	0.0532	CbGpPWpGaD
Meclofenamic acid—PTGS1—nipple—skin cancer	0.0013	0.0216	CbGeAlD
Meclofenamic acid—Ill-defined disorder—Imiquimod—skin cancer	0.00128	0.00711	CcSEcCtD
Meclofenamic acid—Nausea—Vismodegib—skin cancer	0.00127	0.00705	CcSEcCtD
Meclofenamic acid—Malaise—Imiquimod—skin cancer	0.00124	0.00691	CcSEcCtD
Meclofenamic acid—Neutropenia—Dactinomycin—skin cancer	0.00123	0.00681	CcSEcCtD
Meclofenamic acid—Stomatitis—Bleomycin—skin cancer	0.00122	0.00679	CcSEcCtD
Meclofenamic acid—Palpitations—Imiquimod—skin cancer	0.00122	0.00677	CcSEcCtD
Meclofenamic acid—Colitis—Docetaxel—skin cancer	0.00121	0.0067	CcSEcCtD
Meclofenamic acid—SLCO1C1—lymph node—skin cancer	0.00117	0.0194	CbGeAlD
Meclofenamic acid—Discomfort—Imiquimod—skin cancer	0.00116	0.00644	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.00116	0.00644	CcSEcCtD
Meclofenamic acid—Decreased appetite—Vemurafenib—skin cancer	0.00115	0.00637	CcSEcCtD
Meclofenamic acid—Stomatitis—Dactinomycin—skin cancer	0.00114	0.00633	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00114	0.00633	CcSEcCtD
Meclofenamic acid—Fatigue—Vemurafenib—skin cancer	0.00114	0.00632	CcSEcCtD
Meclofenamic acid—Haemoglobin—Bleomycin—skin cancer	0.00113	0.00628	CcSEcCtD
Meclofenamic acid—Constipation—Vemurafenib—skin cancer	0.00113	0.00627	CcSEcCtD
Meclofenamic acid—Oedema—Imiquimod—skin cancer	0.00113	0.00625	CcSEcCtD
Meclofenamic acid—Haemorrhage—Bleomycin—skin cancer	0.00113	0.00625	CcSEcCtD
Meclofenamic acid—Neutropenia—Temozolomide—skin cancer	0.00111	0.00616	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Dactinomycin—skin cancer	0.00109	0.00606	CcSEcCtD
Meclofenamic acid—Eosinophilia—Fluorouracil—skin cancer	0.00108	0.00601	CcSEcCtD
Meclofenamic acid—AKR1C3—lymph node—skin cancer	0.00108	0.0179	CbGeAlD
Meclofenamic acid—Anorexia—Imiquimod—skin cancer	0.00107	0.00596	CcSEcCtD
Meclofenamic acid—Salsalate—PTGS2—skin cancer	0.00106	0.114	CrCbGaD
Meclofenamic acid—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00105	0.00582	CcSEcCtD
Meclofenamic acid—Stomatitis—Temozolomide—skin cancer	0.00103	0.00573	CcSEcCtD
Meclofenamic acid—Insomnia—Imiquimod—skin cancer	0.00102	0.00565	CcSEcCtD
Meclofenamic acid—Paraesthesia—Imiquimod—skin cancer	0.00101	0.00561	CcSEcCtD
Meclofenamic acid—Alopecia—Bleomycin—skin cancer	0.000995	0.00552	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Dactinomycin—skin cancer	0.000993	0.00551	CcSEcCtD
Meclofenamic acid—Decreased appetite—Imiquimod—skin cancer	0.000979	0.00543	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Imiquimod—skin cancer	0.000972	0.0054	CcSEcCtD
Meclofenamic acid—Fatigue—Imiquimod—skin cancer	0.000971	0.00539	CcSEcCtD
Meclofenamic acid—Haemoglobin—Temozolomide—skin cancer	0.000954	0.0053	CcSEcCtD
Meclofenamic acid—Stomatitis—Fluorouracil—skin cancer	0.00095	0.00528	CcSEcCtD
Meclofenamic acid—Haemorrhage—Temozolomide—skin cancer	0.00095	0.00527	CcSEcCtD
Meclofenamic acid—ALOX5—lymph node—skin cancer	0.000949	0.0157	CbGeAlD
Meclofenamic acid—Conjunctivitis—Fluorouracil—skin cancer	0.000947	0.00526	CcSEcCtD
Meclofenamic acid—Asthenia—Vemurafenib—skin cancer	0.000947	0.00526	CcSEcCtD
Meclofenamic acid—Pruritus—Vemurafenib—skin cancer	0.000934	0.00519	CcSEcCtD
Meclofenamic acid—Alopecia—Dactinomycin—skin cancer	0.000928	0.00515	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Imiquimod—skin cancer	0.000928	0.00515	CcSEcCtD
Meclofenamic acid—PTGS1—connective tissue—skin cancer	0.000924	0.0153	CbGeAlD
Meclofenamic acid—Gastrointestinal pain—Imiquimod—skin cancer	0.000921	0.00511	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Fluorouracil—skin cancer	0.00091	0.00505	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Bleomycin—skin cancer	0.000909	0.00505	CcSEcCtD
Meclofenamic acid—Diarrhoea—Vemurafenib—skin cancer	0.000903	0.00502	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Temozolomide—skin cancer	0.000898	0.00499	CcSEcCtD
Meclofenamic acid—Urticaria—Imiquimod—skin cancer	0.000894	0.00497	CcSEcCtD
Meclofenamic acid—Abdominal pain—Imiquimod—skin cancer	0.00089	0.00494	CcSEcCtD
Meclofenamic acid—Tinnitus—Temozolomide—skin cancer	0.000885	0.00492	CcSEcCtD
Meclofenamic acid—Malaise—Bleomycin—skin cancer	0.000884	0.00491	CcSEcCtD
Meclofenamic acid—PTGS2—connective tissue—skin cancer	0.000883	0.0146	CbGeAlD
Meclofenamic acid—Haemoglobin—Fluorouracil—skin cancer	0.000879	0.00488	CcSEcCtD
Meclofenamic acid—Leukopenia—Bleomycin—skin cancer	0.000877	0.00487	CcSEcCtD
Meclofenamic acid—PTGS1—epithelium—skin cancer	0.000877	0.0145	CbGeAlD
Meclofenamic acid—Haemorrhage—Fluorouracil—skin cancer	0.000875	0.00486	CcSEcCtD
Meclofenamic acid—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—skin cancer	0.000869	0.0347	CbGpPWpGaD
Meclofenamic acid—Ill-defined disorder—Dactinomycin—skin cancer	0.000848	0.00471	CcSEcCtD
Meclofenamic acid—Vomiting—Vemurafenib—skin cancer	0.000839	0.00466	CcSEcCtD
Meclofenamic acid—Alopecia—Temozolomide—skin cancer	0.000839	0.00466	CcSEcCtD
Meclofenamic acid—PTGS2—epithelium—skin cancer	0.000838	0.0139	CbGeAlD
Meclofenamic acid—PTGS1—skin of body—skin cancer	0.000834	0.0138	CbGeAlD
Meclofenamic acid—Discomfort—Bleomycin—skin cancer	0.000824	0.00458	CcSEcCtD
Meclofenamic acid—Malaise—Dactinomycin—skin cancer	0.000824	0.00458	CcSEcCtD
Meclofenamic acid—Leukopenia—Dactinomycin—skin cancer	0.000818	0.00454	CcSEcCtD
Meclofenamic acid—Mefenamic acid—PTGS2—skin cancer	0.000809	0.0875	CrCbGaD
Meclofenamic acid—Asthenia—Imiquimod—skin cancer	0.000808	0.00449	CcSEcCtD
Meclofenamic acid—Oedema—Bleomycin—skin cancer	0.0008	0.00444	CcSEcCtD
Meclofenamic acid—PTGS2—skin of body—skin cancer	0.000797	0.0132	CbGeAlD
Meclofenamic acid—Pruritus—Imiquimod—skin cancer	0.000797	0.00442	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—skin cancer	0.000788	0.0852	CrCbGaD
Meclofenamic acid—Nausea—Vemurafenib—skin cancer	0.000784	0.00435	CcSEcCtD
Meclofenamic acid—Vision blurred—Temozolomide—skin cancer	0.000779	0.00433	CcSEcCtD
Meclofenamic acid—Alopecia—Fluorouracil—skin cancer	0.000773	0.00429	CcSEcCtD
Meclofenamic acid—Diarrhoea—Imiquimod—skin cancer	0.00077	0.00428	CcSEcCtD
Meclofenamic acid—Discomfort—Dactinomycin—skin cancer	0.000769	0.00427	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Temozolomide—skin cancer	0.000767	0.00426	CcSEcCtD
Meclofenamic acid—Anorexia—Bleomycin—skin cancer	0.000762	0.00423	CcSEcCtD
Meclofenamic acid—PTGS1—mammalian vulva—skin cancer	0.000761	0.0126	CbGeAlD
Meclofenamic acid—Oedema—Dactinomycin—skin cancer	0.000746	0.00414	CcSEcCtD
Meclofenamic acid—Malaise—Temozolomide—skin cancer	0.000745	0.00414	CcSEcCtD
Meclofenamic acid—Leukopenia—Temozolomide—skin cancer	0.00074	0.00411	CcSEcCtD
Meclofenamic acid—Neutropenia—Docetaxel—skin cancer	0.000738	0.0041	CcSEcCtD
Meclofenamic acid—Palpitations—Temozolomide—skin cancer	0.000731	0.00406	CcSEcCtD
Meclofenamic acid—Paraesthesia—Bleomycin—skin cancer	0.000718	0.00399	CcSEcCtD
Meclofenamic acid—Vision blurred—Fluorouracil—skin cancer	0.000718	0.00399	CcSEcCtD
Meclofenamic acid—Vomiting—Imiquimod—skin cancer	0.000716	0.00397	CcSEcCtD
Meclofenamic acid—Anorexia—Dactinomycin—skin cancer	0.000711	0.00395	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000697	0.00387	CcSEcCtD
Meclofenamic acid—Discomfort—Temozolomide—skin cancer	0.000695	0.00386	CcSEcCtD
Meclofenamic acid—Decreased appetite—Bleomycin—skin cancer	0.000695	0.00386	CcSEcCtD
Meclofenamic acid—Renal failure—Docetaxel—skin cancer	0.000692	0.00384	CcSEcCtD
Meclofenamic acid—Stomatitis—Docetaxel—skin cancer	0.000686	0.00381	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Docetaxel—skin cancer	0.000684	0.0038	CcSEcCtD
Meclofenamic acid—Leukopenia—Fluorouracil—skin cancer	0.000682	0.00379	CcSEcCtD
Meclofenamic acid—Oedema—Temozolomide—skin cancer	0.000675	0.00375	CcSEcCtD
Meclofenamic acid—Nausea—Imiquimod—skin cancer	0.000669	0.00371	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Bleomycin—skin cancer	0.000659	0.00366	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Docetaxel—skin cancer	0.000657	0.00365	CcSEcCtD
Meclofenamic acid—PTGS1—female reproductive system—skin cancer	0.000651	0.0108	CbGeAlD
Meclofenamic acid—Salicylic acid—PTGS2—skin cancer	0.000649	0.0702	CrCbGaD
Meclofenamic acid—Decreased appetite—Dactinomycin—skin cancer	0.000648	0.0036	CcSEcCtD
Meclofenamic acid—PTGS2—lymphoid tissue—skin cancer	0.000645	0.0107	CbGeAlD
Meclofenamic acid—Fatigue—Dactinomycin—skin cancer	0.000643	0.00357	CcSEcCtD
Meclofenamic acid—Anorexia—Temozolomide—skin cancer	0.000643	0.00357	CcSEcCtD
Meclofenamic acid—Discomfort—Fluorouracil—skin cancer	0.000641	0.00356	CcSEcCtD
Meclofenamic acid—Urticaria—Bleomycin—skin cancer	0.000635	0.00353	CcSEcCtD
Meclofenamic acid—Haemoglobin—Docetaxel—skin cancer	0.000635	0.00352	CcSEcCtD
Meclofenamic acid—Haemorrhage—Docetaxel—skin cancer	0.000632	0.00351	CcSEcCtD
Meclofenamic acid—PTGS2—female reproductive system—skin cancer	0.000623	0.0103	CbGeAlD
Meclofenamic acid—Oedema—Fluorouracil—skin cancer	0.000622	0.00345	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Dactinomycin—skin cancer	0.000615	0.00341	CcSEcCtD
Meclofenamic acid—Insomnia—Temozolomide—skin cancer	0.00061	0.00339	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Dactinomycin—skin cancer	0.00061	0.00339	CcSEcCtD
Meclofenamic acid—Paraesthesia—Temozolomide—skin cancer	0.000606	0.00336	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Docetaxel—skin cancer	0.000597	0.00332	CcSEcCtD
Meclofenamic acid—Anorexia—Fluorouracil—skin cancer	0.000593	0.00329	CcSEcCtD
Meclofenamic acid—Abdominal pain—Dactinomycin—skin cancer	0.00059	0.00327	CcSEcCtD
Meclofenamic acid—Decreased appetite—Temozolomide—skin cancer	0.000587	0.00326	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Temozolomide—skin cancer	0.000582	0.00323	CcSEcCtD
Meclofenamic acid—Fatigue—Temozolomide—skin cancer	0.000582	0.00323	CcSEcCtD
Meclofenamic acid—Diclofenac—PTGS2—skin cancer	0.000581	0.0628	CrCbGaD
Meclofenamic acid—Constipation—Temozolomide—skin cancer	0.000577	0.0032	CcSEcCtD
Meclofenamic acid—Asthenia—Bleomycin—skin cancer	0.000574	0.00319	CcSEcCtD
Meclofenamic acid—ALOX5—Eicosanoid Synthesis—PTGS2—skin cancer	0.000567	0.0226	CbGpPWpGaD
Meclofenamic acid—Pruritus—Bleomycin—skin cancer	0.000566	0.00314	CcSEcCtD
Meclofenamic acid—Insomnia—Fluorouracil—skin cancer	0.000562	0.00312	CcSEcCtD
Meclofenamic acid—Paraesthesia—Fluorouracil—skin cancer	0.000558	0.0031	CcSEcCtD
Meclofenamic acid—Alopecia—Docetaxel—skin cancer	0.000558	0.0031	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Temozolomide—skin cancer	0.000556	0.00309	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Temozolomide—skin cancer	0.000552	0.00306	CcSEcCtD
Meclofenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.000545	0.0217	CbGpPWpGaD
Meclofenamic acid—PTGS1—head—skin cancer	0.000544	0.00902	CbGeAlD
Meclofenamic acid—Decreased appetite—Fluorouracil—skin cancer	0.00054	0.003	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000537	0.00298	CcSEcCtD
Meclofenamic acid—Urticaria—Temozolomide—skin cancer	0.000536	0.00298	CcSEcCtD
Meclofenamic acid—SLCO1C1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000536	0.0214	CbGpPWpGaD
Meclofenamic acid—Asthenia—Dactinomycin—skin cancer	0.000535	0.00297	CcSEcCtD
Meclofenamic acid—Abdominal pain—Temozolomide—skin cancer	0.000533	0.00296	CcSEcCtD
Meclofenamic acid—PTGS2—head—skin cancer	0.00052	0.00863	CbGeAlD
Meclofenamic acid—Feeling abnormal—Fluorouracil—skin cancer	0.000512	0.00284	CcSEcCtD
Meclofenamic acid—Diarrhoea—Dactinomycin—skin cancer	0.00051	0.00283	CcSEcCtD
Meclofenamic acid—Vomiting—Bleomycin—skin cancer	0.000509	0.00282	CcSEcCtD
Meclofenamic acid—KCNQ2—Axon guidance—SCN10A—skin cancer	0.000504	0.0201	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—SCN10A—skin cancer	0.000504	0.0201	CbGpPWpGaD
Meclofenamic acid—Urticaria—Fluorouracil—skin cancer	0.000494	0.00274	CcSEcCtD
Meclofenamic acid—Leukopenia—Docetaxel—skin cancer	0.000492	0.00273	CcSEcCtD
Meclofenamic acid—Palpitations—Docetaxel—skin cancer	0.000486	0.0027	CcSEcCtD
Meclofenamic acid—Asthenia—Temozolomide—skin cancer	0.000484	0.00269	CcSEcCtD
Meclofenamic acid—Pruritus—Temozolomide—skin cancer	0.000477	0.00265	CcSEcCtD
Meclofenamic acid—Nausea—Bleomycin—skin cancer	0.000475	0.00264	CcSEcCtD
Meclofenamic acid—Vomiting—Dactinomycin—skin cancer	0.000474	0.00263	CcSEcCtD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.000462	0.0184	CbGpPWpGaD
Meclofenamic acid—Diarrhoea—Temozolomide—skin cancer	0.000462	0.00256	CcSEcCtD
Meclofenamic acid—Oedema—Docetaxel—skin cancer	0.000449	0.00249	CcSEcCtD
Meclofenamic acid—Nausea—Dactinomycin—skin cancer	0.000443	0.00246	CcSEcCtD
Meclofenamic acid—Pruritus—Fluorouracil—skin cancer	0.00044	0.00244	CcSEcCtD
Meclofenamic acid—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.000432	0.0173	CbGpPWpGaD
Meclofenamic acid—Vomiting—Temozolomide—skin cancer	0.000429	0.00238	CcSEcCtD
Meclofenamic acid—Anorexia—Docetaxel—skin cancer	0.000428	0.00237	CcSEcCtD
Meclofenamic acid—Diarrhoea—Fluorouracil—skin cancer	0.000425	0.00236	CcSEcCtD
Meclofenamic acid—Insomnia—Docetaxel—skin cancer	0.000406	0.00225	CcSEcCtD
Meclofenamic acid—Paraesthesia—Docetaxel—skin cancer	0.000403	0.00224	CcSEcCtD
Meclofenamic acid—Nausea—Temozolomide—skin cancer	0.000401	0.00223	CcSEcCtD
Meclofenamic acid—Vomiting—Fluorouracil—skin cancer	0.000395	0.00219	CcSEcCtD
Meclofenamic acid—Decreased appetite—Docetaxel—skin cancer	0.00039	0.00217	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Docetaxel—skin cancer	0.000387	0.00215	CcSEcCtD
Meclofenamic acid—Fatigue—Docetaxel—skin cancer	0.000387	0.00215	CcSEcCtD
Meclofenamic acid—Constipation—Docetaxel—skin cancer	0.000384	0.00213	CcSEcCtD
Meclofenamic acid—PTGS1—lymph node—skin cancer	0.000381	0.00632	CbGeAlD
Meclofenamic acid—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—skin cancer	0.000378	0.0151	CbGpPWpGaD
Meclofenamic acid—Feeling abnormal—Docetaxel—skin cancer	0.00037	0.00205	CcSEcCtD
Meclofenamic acid—Nausea—Fluorouracil—skin cancer	0.000369	0.00205	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Docetaxel—skin cancer	0.000367	0.00204	CcSEcCtD
Meclofenamic acid—PTGS2—lymph node—skin cancer	0.000364	0.00604	CbGeAlD
Meclofenamic acid—KCNQ2—Developmental Biology—SCN10A—skin cancer	0.00036	0.0144	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—SCN10A—skin cancer	0.00036	0.0144	CbGpPWpGaD
Meclofenamic acid—Abdominal pain—Docetaxel—skin cancer	0.000355	0.00197	CcSEcCtD
Meclofenamic acid—Asthenia—Docetaxel—skin cancer	0.000322	0.00179	CcSEcCtD
Meclofenamic acid—Pruritus—Docetaxel—skin cancer	0.000317	0.00176	CcSEcCtD
Meclofenamic acid—ALOX5—Arachidonic acid metabolism—PTGS2—skin cancer	0.000315	0.0126	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Arachidonic acid metabolism—PTGS2—skin cancer	0.000314	0.0125	CbGpPWpGaD
Meclofenamic acid—Diarrhoea—Docetaxel—skin cancer	0.000307	0.0017	CcSEcCtD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—PTGS2—skin cancer	0.000296	0.0118	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—RASA1—skin cancer	0.00029	0.0116	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—RASA1—skin cancer	0.00029	0.0116	CbGpPWpGaD
Meclofenamic acid—Vomiting—Docetaxel—skin cancer	0.000285	0.00158	CcSEcCtD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000272	0.0109	CbGpPWpGaD
Meclofenamic acid—Nausea—Docetaxel—skin cancer	0.000267	0.00148	CcSEcCtD
Meclofenamic acid—PTGS1—Eicosanoid Synthesis—PTGS2—skin cancer	0.000246	0.0098	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000236	0.00941	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000235	0.00938	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CSPG4—skin cancer	0.00023	0.00919	CbGpPWpGaD
Meclofenamic acid—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000224	0.00895	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—RASA1—skin cancer	0.000207	0.00825	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—RASA1—skin cancer	0.000207	0.00825	CbGpPWpGaD
Meclofenamic acid—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	0.000206	0.0082	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—PTGS2—skin cancer	0.0002	0.008	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RHOU—skin cancer	0.000191	0.0076	CbGpPWpGaD
Meclofenamic acid—PTGS1—Overview of nanoparticle effects—IL6—skin cancer	0.000161	0.00644	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	0.000152	0.00605	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—BRAF—skin cancer	0.000142	0.00565	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—BRAF—skin cancer	0.000142	0.00565	CbGpPWpGaD
Meclofenamic acid—PTGS1—Arachidonic acid metabolism—PTGS2—skin cancer	0.000137	0.00545	CbGpPWpGaD
Meclofenamic acid—PTGS2—Overview of nanoparticle effects—IL6—skin cancer	0.000128	0.00511	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000114	0.00455	CbGpPWpGaD
Meclofenamic acid—ALOX5—Selenium Micronutrient Network—IL6—skin cancer	0.000109	0.00436	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000107	0.00425	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PLIN2—skin cancer	0.000105	0.00419	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PLIN2—skin cancer	0.000105	0.00418	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000102	0.00408	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—CDK4—skin cancer	0.000101	0.00404	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—CDK4—skin cancer	0.000101	0.00404	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000101	0.00403	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CSPG4—skin cancer	0.000101	0.00402	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTCH2—skin cancer	9.31e-05	0.00371	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	9.02e-05	0.0036	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—PTGS2—skin cancer	8.69e-05	0.00347	CbGpPWpGaD
Meclofenamic acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	8.58e-05	0.00343	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CSPG4—skin cancer	8.47e-05	0.00338	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CSPG4—skin cancer	8.44e-05	0.00337	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	8.12e-05	0.00324	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—NRAS—skin cancer	7.9e-05	0.00315	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—NRAS—skin cancer	7.9e-05	0.00315	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	7.76e-05	0.0031	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—CDKN2A—skin cancer	7.66e-05	0.00306	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CDK4—skin cancer	7.63e-05	0.00305	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—GLI2—skin cancer	7.05e-05	0.00281	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SHH—skin cancer	6.85e-05	0.00273	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ENO2—skin cancer	6.85e-05	0.00273	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—KRAS—skin cancer	6.8e-05	0.00271	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—KRAS—skin cancer	6.8e-05	0.00271	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MC1R—skin cancer	6.73e-05	0.00269	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—GLI1—skin cancer	6.63e-05	0.00265	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	6.6e-05	0.00263	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—HRAS—skin cancer	6.51e-05	0.0026	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—HRAS—skin cancer	6.51e-05	0.0026	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SUFU—skin cancer	6.29e-05	0.00251	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—HRAS—skin cancer	5.78e-05	0.00231	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—HRAS—skin cancer	5.78e-05	0.00231	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ENO2—skin cancer	5.76e-05	0.0023	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ENO2—skin cancer	5.73e-05	0.00229	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—NRAS—skin cancer	5.64e-05	0.00225	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—NRAS—skin cancer	5.64e-05	0.00225	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—FOXO4—skin cancer	5.58e-05	0.00223	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	5.57e-05	0.00222	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—IL6—skin cancer	5.53e-05	0.00221	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—IL6—skin cancer	5.53e-05	0.00221	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	5.19e-05	0.00207	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—KRAS—skin cancer	4.85e-05	0.00194	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—KRAS—skin cancer	4.85e-05	0.00194	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SHH—skin cancer	4.79e-05	0.00191	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	4.79e-05	0.00191	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RASA1—skin cancer	4.76e-05	0.0019	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	4.73e-05	0.00189	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PLIN2—skin cancer	4.55e-05	0.00182	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SMO—skin cancer	4.54e-05	0.00181	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTCH1—skin cancer	4.54e-05	0.00181	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.5e-05	0.0018	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.48e-05	0.00179	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTGER4—skin cancer	4.42e-05	0.00177	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—HRAS—skin cancer	4.12e-05	0.00165	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—HRAS—skin cancer	4.12e-05	0.00165	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	4.07e-05	0.00163	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ERCC2—skin cancer	3.98e-05	0.00159	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—IL6—skin cancer	3.95e-05	0.00157	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—IL6—skin cancer	3.95e-05	0.00157	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FOXO4—skin cancer	3.91e-05	0.00156	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	3.76e-05	0.0015	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TERT—skin cancer	3.73e-05	0.00149	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CSPG4—skin cancer	3.67e-05	0.00147	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PLIN2—skin cancer	3.62e-05	0.00144	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CSPG4—skin cancer	3.48e-05	0.00139	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ERCC2—skin cancer	3.34e-05	0.00133	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ERCC2—skin cancer	3.33e-05	0.00133	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TP53—skin cancer	3.25e-05	0.0013	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL6—skin cancer	2.97e-05	0.00119	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—BRAF—skin cancer	2.95e-05	0.00118	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CSPG4—skin cancer	2.91e-05	0.00116	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TERT—skin cancer	2.61e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ENO2—skin cancer	2.5e-05	0.000996	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	2.48e-05	0.000992	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—skin cancer	2.38e-05	0.000952	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ENO2—skin cancer	2.37e-05	0.000944	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SHH—skin cancer	2.37e-05	0.000944	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.21e-05	0.000881	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—BRAF—skin cancer	2.07e-05	0.000825	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—skin cancer	2e-05	0.0008	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—skin cancer	2e-05	0.000797	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ENO2—skin cancer	1.98e-05	0.000791	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.95e-05	0.000779	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FOXO4—skin cancer	1.93e-05	0.00077	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NRAS—skin cancer	1.86e-05	0.00074	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—skin cancer	1.6e-05	0.000637	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ERCC2—skin cancer	1.45e-05	0.000579	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERCC2—skin cancer	1.37e-05	0.000548	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—skin cancer	1.36e-05	0.000542	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NRAS—skin cancer	1.3e-05	0.000518	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—IL6—skin cancer	1.3e-05	0.000518	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TERT—skin cancer	1.29e-05	0.000514	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ERCC2—skin cancer	1.15e-05	0.000459	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—skin cancer	1.12e-05	0.000446	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—BRAF—skin cancer	1.02e-05	0.000407	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—skin cancer	9.94e-06	0.000397	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—skin cancer	9.5e-06	0.000379	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL6—skin cancer	9.1e-06	0.000363	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—skin cancer	8.69e-06	0.000347	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NRAS—skin cancer	6.41e-06	0.000256	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—skin cancer	5.52e-06	0.00022	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—skin cancer	4.69e-06	0.000187	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—IL6—skin cancer	4.49e-06	0.000179	CbGpPWpGaD
